Bayer announced regarding discontinuing supply of 'Kogenate FS' that they can supply the drug constantly to 20 patients

According to the Korea Hemophilia Association, on July 1, Bayer announced regarding discontinuing supply of 'Kogenate FS' that they can supply the drug constantly to 20 patients, and continue supplying Kogenate FS to patients for whom it is difficult to substitute with alternative drug. However, in order to receive Kogenate FS, hospital doctor should conduct tests in accordance with the applica...